{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:40:57Z","timestamp":1794487257572,"version":"4.9.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["F31AG074672"],"award-info":[{"award-number":["F31AG074672"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG061150"],"award-info":[{"award-number":["R01AG061150"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["F31AG074690"],"award-info":[{"award-number":["F31AG074690"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG071697"],"award-info":[{"award-number":["R01AG071697"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG073082"],"award-info":[{"award-number":["P01AG073082"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Apolipoprotein E4 (\n                    <jats:italic>APOE4<\/jats:italic>\n                    ) is the strongest known genetic risk factor for late-onset Alzheimer\u2019s disease (AD). Conditions of stress or injury induce APOE expression within neurons, but the role of neuronal APOE4 in AD pathogenesis is still unclear. Here we report the characterization of neuronal APOE4 effects on AD-related pathologies in an APOE4-expressing tauopathy mouse model. The selective genetic removal of APOE4 from neurons led to a significant reduction in tau pathology, gliosis, neurodegeneration, neuronal hyperexcitability and myelin deficits. Single-nucleus RNA-sequencing revealed that the removal of neuronal APOE4 greatly diminished neurodegenerative disease-associated subpopulations of neurons, oligodendrocytes, astrocytes and microglia whose accumulation correlated to the severity of tau pathology, neurodegeneration and myelin deficits. Thus, neuronal APOE4 plays a central role in promoting the development of major AD pathologies and its removal can mitigate the progressive cellular and tissue alterations occurring in this model of APOE4-driven tauopathy.\n                  <\/jats:p>","DOI":"10.1038\/s43587-023-00368-3","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T12:03:22Z","timestamp":1676894602000},"page":"275-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":139,"title":["Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-1480","authenticated-orcid":false,"given":"Nicole","family":"Koutsodendris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Blumenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2940-8926","authenticated-orcid":false,"given":"Ayushi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Traglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Grone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-8312","authenticated-orcid":false,"given":"Misha","family":"Zilberter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9096-7167","authenticated-orcid":false,"given":"Oscar","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1269-018X","authenticated-orcid":false,"given":"Antara","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine R.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Yeon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Arriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-4589","authenticated-orcid":false,"given":"Yadong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"368_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tips.2017.03.011","volume":"38","author":"ME Orr","year":"2017","unstructured":"Orr, M. E., Sullivan, A. C. & Frost, B. A brief overview of tauopathy: causes, consequences, and therapeutic strategies. Trends Pharmacol. Sci. 38, 637\u2013648 (2017).","journal-title":"Trends Pharmacol. Sci."},{"key":"368_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbadis.2004.10.011","volume":"1739","author":"KS Kosik","year":"2005","unstructured":"Kosik, K. S. & Shimura, H. Phosphorylated tau and the neurodegenerative foldopathies. Biochim. Biophys. Acta 1739, 298\u2013310 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"368_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore, C., Lee, V. M. Y. & Trojanowski, J. Q. Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat. Rev. Neurosci. 8, 663\u2013672 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"368_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang, Y. & Mucke, L. Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204\u20131222 (2012).","journal-title":"Cell"},{"key":"368_CR5","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/alz.12362","volume":"17","author":"KB Rajan","year":"2021","unstructured":"Rajan, K. B. et al. Population estimate of people with clinical Alzheimer\u2019s disease and mild cognitive impairment in the United States (2020\u20132060). Alzheimers Dement. 17, 1966\u20131975 (2021).","journal-title":"Alzheimers Dement."},{"key":"368_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/ana.21223","volume":"63","author":"KA Josephs","year":"2008","unstructured":"Josephs, K. A. et al. \u03b2-amyloid burden is not associated with rates of brain atrophy. Ann. Neurol. 63, 204\u2013212 (2008).","journal-title":"Ann. Neurol."},{"key":"368_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.24711","volume":"80","author":"H Cho","year":"2016","unstructured":"Cho, H. et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann. Neurol. 80, 247\u2013258 (2016).","journal-title":"Ann. Neurol."},{"key":"368_CR8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Scholl","year":"2016","unstructured":"Scholl, M. et al. PET imaging of tau deposition in the aging human brain. Neuron 89, 971\u2013982 (2016).","journal-title":"Neuron"},{"key":"368_CR9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele, R. et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain 139, 1551\u20131567 (2016).","journal-title":"Brain"},{"key":"368_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","volume":"12","author":"CEG Leyns","year":"2017","unstructured":"Leyns, C. E. G. & Holtzman, D. M. Glial contributions to neurodegeneration in tauopathies. Mol. Neurodegener. 12, 50 (2017).","journal-title":"Mol. Neurodegener."},{"key":"368_CR11","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi, Y. et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J. Exp. Med. 216, 2546\u20132561 (2019).","journal-title":"J. Exp. Med."},{"key":"368_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.nicl.2013.11.001","volume":"4","author":"A Benitez","year":"2013","unstructured":"Benitez, A. et al. White matter tract integrity metrics reflect the vulnerability of late-myelinating tracts in Alzheimer\u2019s disease. Neuroimage Clin. 4, 64\u201371 (2013).","journal-title":"Neuroimage Clin."},{"key":"368_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamaneurol.2016.3232","volume":"74","author":"DC Dean III","year":"2017","unstructured":"Dean, D. C. III et al. Association of amyloid pathology with myelin alteration in preclinical Alzheimer disease. JAMA Neurol. 74, 41\u201349 (2017).","journal-title":"JAMA Neurol."},{"key":"368_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady, S. E., Rizvi, B., Goldman, J. E. & Brickman, A. M. White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol. Commun. 6, 22 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"368_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/glia.20734","volume":"57","author":"MK Desai","year":"2009","unstructured":"Desai, M. K. et al. Triple-transgenic Alzheimer\u2019s disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia 57, 54\u201365 (2009).","journal-title":"Glia"},{"key":"368_CR16","doi-asserted-by":"publisher","first-page":"eabb8680","DOI":"10.1126\/sciadv.abb8680","volume":"6","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer\u2019s disease. Sci. Adv. 6, eabb8680 (2020).","journal-title":"Sci. Adv."},{"key":"368_CR17","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.neuron.2021.05.034","volume":"109","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms. Neuron 109, 2413\u20132426 (2021).","journal-title":"Neuron"},{"key":"368_CR18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late-onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"368_CR19","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders, A. M. et al. Association of apolipoprotein E allele \u03f54 with late-onset familial and sporadic alzheimer\u2019s disease. Neurology 43, 1467\u20131472 (1993).","journal-title":"Neurology"},{"key":"368_CR20","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat. Genet. 45, 1452\u20131458 (2013).","journal-title":"Nat. Genet."},{"key":"368_CR21","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349\u20131356 (1997).","journal-title":"JAMA"},{"key":"368_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C. C. & Bu, G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurol. 15, 501\u2013518 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"368_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-pathmechdis-030421-112756","volume":"17","author":"N Koutsodendris","year":"2022","unstructured":"Koutsodendris, N., Nelson, M. R., Rao, A. & Huang, Y. Apolipoprotein E and Alzheimer\u2019s disease: findings, hypotheses, and potential mechanisms. Ann. Rev. Pathol. 17, 73\u201399 (2022).","journal-title":"Ann. Rev. Pathol."},{"key":"368_CR24","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/brain\/awy103","volume":"141","author":"S Mishra","year":"2018","unstructured":"Mishra, S. et al. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE \u03f54 genotype. Brain 141, 1828\u20131839 (2018).","journal-title":"Brain"},{"key":"368_CR25","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1523\/JNEUROSCI.19-12-04867.1999","volume":"19","author":"M Buttini","year":"1999","unstructured":"Buttini, M. et al. Expression of human apolipoprotein E3 or E4 in the brains of Apoe\u2212\/\u2212 mice: isoform-specific effects on neurodegeneration. J. Neurosci. 19, 4867\u20134880 (1999).","journal-title":"J. Neurosci."},{"key":"368_CR26","doi-asserted-by":"publisher","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","volume":"30","author":"Y Andrews-Zwilling","year":"2010","unstructured":"Andrews-Zwilling, Y. et al. Apolipoprotein E4 causes age- and tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J. Neurosci. 30, 13707\u201313717 (2010).","journal-title":"J. Neurosci."},{"key":"368_CR27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s41593-021-00851-3","volume":"24","author":"KA Zalocusky","year":"2021","unstructured":"Zalocusky, K. A. et al. Neuronal apoE upregulates MHC pathways to drive selective neurodegeneration in Alzheimer\u2019s disease. Nat. Neurosci. 24, 786\u2013798 (2021).","journal-title":"Nat. Neurosci."},{"key":"368_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523\u2013527 (2017).","journal-title":"Nature"},{"key":"368_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","volume":"77","author":"J Therriault","year":"2020","unstructured":"Therriault, J. et al. Association of apolipoprotein e \u03f54 with medial temporal tau independent of amyloid-\u03b2. JAMA Neurol. 77, 470\u2013479 (2020).","journal-title":"JAMA Neurol."},{"key":"368_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13195-020-00710-6","volume":"12","author":"MS Baek","year":"2020","unstructured":"Baek, M. S. et al. Effect of APOE \u03b54 genotype on amyloid-\u03b2 and tau accumulation in Alzheimer\u2019s disease. Alzheimers Res. Ther. 12, 140 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"368_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med. 24, 647\u2013657 (2018).","journal-title":"Nat. Med."},{"key":"368_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"Y-T Lin","year":"2018","unstructured":"Lin, Y.-T. et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1141\u20131154 (2018).","journal-title":"Neuron"},{"key":"368_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-19264-0","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao, J. et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat. Commun. 11, 1\u201314 (2020).","journal-title":"Nat. Commun."},{"key":"368_CR34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0002-9440(10)64963-2","volume":"156","author":"I Tesseur","year":"2000","unstructured":"Tesseur, I. et al. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am. J. Pathol. 156, 951\u2013964 (2000).","journal-title":"Am. J. Pathol."},{"key":"368_CR35","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht, W. J. et al. Neuron-specific apolipoprotein E4 proteolysis is associated with increased Tau phosphorylation in brains of transgenic mice. J. Neurosci. 24, 2527\u20132534 (2004).","journal-title":"J. Neurosci."},{"key":"368_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jaci.2014.01.032","volume":"134","author":"SC Gale","year":"2014","unstructured":"Gale, S. C. et al. APO\u03b54 is associated with enhanced in vivo innate immune responses in human subjects. J. Allergy Clin. Immunol. 134, 127\u2013134 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"368_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1750-3639.1998.tb00166.x","volume":"8","author":"R Egensperger","year":"1998","unstructured":"Egensperger, R., K\u00f6sel, S., Von Eitzen, U. & Graeber, M. B. Microglial activation in Alzheimer disease: association with APOE genotype. Brain Pathol. 8, 439\u2013447 (1998).","journal-title":"Brain Pathol."},{"key":"368_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000017128","volume":"10","author":"M Overmyer","year":"1999","unstructured":"Overmyer, M. et al. Astrogliosis and the ApoE genotype: an immunohistochemical study of postmortem human brain tissue. Demet. Geriatr. Cogn. Disord. 10, 252\u2013257 (1999).","journal-title":"Demet. Geriatr. Cogn. Disord."},{"key":"368_CR39","doi-asserted-by":"publisher","first-page":"101983","DOI":"10.1016\/j.nicl.2019.101983","volume":"24","author":"G Operto","year":"2019","unstructured":"Operto, G. et al. Interactive effect of age and APOE-E4 allele load on white matter myelin content in cognitively normal middle-aged subjects. Neuroimage Clin. 24, 101983 (2019).","journal-title":"Neuroimage Clin."},{"key":"368_CR40","doi-asserted-by":"publisher","first-page":"14069","DOI":"10.1523\/JNEUROSCI.2281-14.2014","volume":"34","author":"J Knoferle","year":"2014","unstructured":"Knoferle, J. et al. Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice. J. Neurosci. 34, 14069\u201314078 (2014).","journal-title":"J. Neurosci."},{"key":"368_CR41","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron 109, 1657\u20131674 (2021).","journal-title":"Neuron"},{"key":"368_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1385\/JMN:23:3:189","volume":"189","author":"Y Huang","year":"2004","unstructured":"Huang, Y., Weisgraber, K. H., Mucke, L. & Mahley, R. W. Apolipoprotein E diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer\u2019s disease. J. Mol. Neurosci. 189, 189\u2013204 (2004).","journal-title":"J. Mol. Neurosci."},{"key":"368_CR43","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu, Q. et al. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the apoE locus. J. Neurosci. 26, 4985\u20134994 (2006).","journal-title":"J. Neurosci."},{"key":"368_CR44","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1523\/JNEUROSCI.3253-07.2008","volume":"28","author":"Q Xu","year":"2008","unstructured":"Xu, Q. et al. Intron-3 retention\/splicing controls neuronal expression of apolipoprotein E in the CNS. J. Neurosci. 28, 1452\u20131459 (2008).","journal-title":"J. Neurosci."},{"key":"368_CR45","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1523\/JNEUROSCI.0033-12.2012","volume":"32","author":"N Bien-Ly","year":"2012","unstructured":"Bien-Ly, N., Gillespie, A. K., Walker, D., Yoon, S. Y. & Huang, Y. Reducing human apolipoprotein E levels attenuates age-aependent A\u03b2 accumulation in mutant human amyloid precursor protein transgenic mice. J. Neurosci. 32, 4803\u20134811 (2012).","journal-title":"J. Neurosci."},{"key":"368_CR46","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1101\/gad.862101","volume":"15","author":"Y Zhu","year":"2001","unstructured":"Zhu, Y. et al. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 15, 859\u2013876 (2001).","journal-title":"Genes Dev."},{"key":"368_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337\u2013351 (2007).","journal-title":"Neuron"},{"key":"368_CR48","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0896-6273(00)81127-7","volume":"24","author":"T Ishihara","year":"1999","unstructured":"Ishihara, T. et al. Age-dependent emergence and progression of tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751\u2013762 (1999).","journal-title":"Neuron"},{"key":"368_CR49","first-page":"2064","volume":"9","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Cao, Y., Ma, L., Wei, Y. & Li, H. Possible mechanisms of tau spread and toxicity in Alzheimer\u2019s disease. Front. Cell Dev. Biol. 9, 2064 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"368_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fnins.2018.00267","volume":"12","author":"SL DeVos","year":"2018","unstructured":"DeVos, S. L. et al. Synaptic tau seeding precedes tau pathology in human Alzheimer\u2019s disease brain. Front. Neurosci. 12, 267 (2018).","journal-title":"Front. Neurosci."},{"key":"368_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-014-1373-0","volume":"129","author":"S Boluda","year":"2015","unstructured":"Boluda, S. et al. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer\u2019s disease or corticobasal degeneration brains. Acta Neuropathol. 129, 221\u2013237 (2015).","journal-title":"Acta Neuropathol."},{"key":"368_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nbd.2014.08.032","volume":"73","author":"E Peeraer","year":"2015","unstructured":"Peeraer, E. et al. Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice. Neurobiol. Dis. 73, 83\u201395 (2015).","journal-title":"Neurobiol. Dis."},{"key":"368_CR53","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1084\/jem.20160833","volume":"213","author":"JL Guo","year":"2016","unstructured":"Guo, J. L. et al. Unique pathological tau conformers from Alzheimer\u2019s brains transmit tau pathology in nontransgenic mice. J. Exp. Med. 213, 2635\u20132654 (2016).","journal-title":"J. Exp. Med."},{"key":"368_CR54","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","volume":"92","author":"SK Kaufman","year":"2016","unstructured":"Kaufman, S. K. et al. Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92, 796\u2013812 (2016).","journal-title":"Neuron"},{"key":"368_CR55","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch, J. N. et al. LRP1 is a master regulator of tau uptake and spread. Nature 580, 381\u2013385 (2020).","journal-title":"Nature"},{"key":"368_CR56","doi-asserted-by":"publisher","first-page":"16383","DOI":"10.1523\/JNEUROSCI.3411-10.2010","volume":"30","author":"RB Tripathi","year":"2010","unstructured":"Tripathi, R. B., Rivers, L. E., Young, K. M., Jamen, F. & Richardson, W. D. NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J. Neurosci. 30, 16383\u201316390 (2010).","journal-title":"J. Neurosci."},{"key":"368_CR57","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s43587-021-00122-7","volume":"1","author":"A Taubes","year":"2021","unstructured":"Taubes, A. et al. Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer\u2019s disease. Nat. Aging 1, 932\u2013947 (2021).","journal-title":"Nat. Aging"},{"key":"368_CR58","doi-asserted-by":"publisher","first-page":"P10008","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","volume":"2008","author":"VD Blondel","year":"2008","unstructured":"Blondel, V. D., Guillaume, J. L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. 2008, P10008 (2008).","journal-title":"J. Stat. Mech."},{"key":"368_CR59","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.neuron.2022.06.021","volume":"110","author":"M Otero-Garcia","year":"2022","unstructured":"Otero-Garcia, M. et al. Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer\u2019s disease. Neuron 110, 2929\u20132948 (2022).","journal-title":"Neuron"},{"key":"368_CR60","doi-asserted-by":"crossref","unstructured":"Anon. Changes in the expression profiles of oligodendrocytes are shared in different brain pathologies. Nat. Neurosci. 25, 845\u2013846 (2022).","DOI":"10.1038\/s41593-022-01105-6"},{"key":"368_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0601-z","volume":"13","author":"T Minett","year":"2016","unstructured":"Minett, T. et al. Microglial immunophenotype in dementia with Alzheimer\u2019s pathology. J. Neuroinflammation 13, 135 (2016).","journal-title":"J. Neuroinflammation"},{"key":"368_CR62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1006\/cbir.1999.0451","volume":"24","author":"SM Cerutti","year":"2000","unstructured":"Cerutti, S. M. & Chadi, G. S100 immunoreactivity is increased in reactive astrocytes of the visual pathways following a mechanical lesion of the rat occipital cortex. Cell Biol. Int. 24, 35\u201349 (2000).","journal-title":"Cell Biol. Int."},{"key":"368_CR63","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib, N. et al. Disease-associated astrocytes in Alzheimer\u2019s disease and aging. Nat. Neurosci. 23, 701\u2013706 (2020).","journal-title":"Nat. Neurosci."},{"key":"368_CR64","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290 (2017).","journal-title":"Cell"},{"key":"368_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15701-2","volume":"11","author":"JW Vogel","year":"2020","unstructured":"Vogel, J. W. et al. Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease. Nat. Commun. 11, 2612 (2020).","journal-title":"Nat. Commun."},{"key":"368_CR66","doi-asserted-by":"publisher","first-page":"111189","DOI":"10.1016\/j.celrep.2022.111189","volume":"40","author":"S Pandey","year":"2022","unstructured":"Pandey, S. et al. Disease-associated oligodendrocyte responses across neurodegenerative diseases. Cell Rep. 40, 111189 (2022).","journal-title":"Cell Rep."},{"key":"368_CR67","doi-asserted-by":"publisher","first-page":"786353","DOI":"10.3389\/fneur.2021.786353","volume":"12","author":"L Li","year":"2022","unstructured":"Li, L., Jiang, Y., Wang, J. Z., Liu, R. & Wang, X. Tau ubiquitination in Alzheimer\u2019s disease. Front. Neurol. 12, 786353 (2022).","journal-title":"Front. Neurol."},{"key":"368_CR68","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1073\/pnas.0701055104","volume":"104","author":"W Luo","year":"2007","unstructured":"Luo, W. et al. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies. Proc. Natl Acad. Sci. USA 104, 9511\u20139516 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"368_CR69","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13024-018-0266-4","volume":"13","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju, S. et al. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer\u2019s disease-related proteins. Mol. Neurodegener. 13, 34 (2018).","journal-title":"Mol. Neurodegener."},{"key":"368_CR70","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1016\/j.neurobiolaging.2014.06.004","volume":"35","author":"M Orre","year":"2014","unstructured":"Orre, M. et al. Isolation of glia from Alzheimer\u2019s mice reveals inflammation and dysfunction. Neurobiol. Aging 35, 2746\u20132760 (2014).","journal-title":"Neurobiol. Aging"},{"key":"368_CR71","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/glia.24105","volume":"70","author":"CM Henningfield","year":"2022","unstructured":"Henningfield, C. M., Arreola, M. A., Soni, N., Spangenberg, E. E. & Green, K. N. Microglia-specific ApoE knock-out does not alter Alzheimer\u2019s disease plaque pathogenesis or gene expression. Glia 70, 287\u2013302 (2022).","journal-title":"Glia"},{"key":"368_CR72","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.26043","volume":"89","author":"A Litvinchuk","year":"2021","unstructured":"Litvinchuk, A. et al. ApoE4 reduction with ASOs decreases neurodegeneration in a tauopathy model. Ann. Neurol. 89, 952\u2013966 (2021).","journal-title":"Ann. Neurol."},{"key":"368_CR73","doi-asserted-by":"publisher","first-page":"8262","DOI":"10.3390\/ijms22158262","volume":"22","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. Features of lipid metabolism in humanized apoe knockin rat models. Int. J. Mol. Sci. 22, 8262 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"368_CR74","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.stem.2009.10.015","volume":"5","author":"G Li","year":"2009","unstructured":"Li, G. et al. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell 5, 634\u2013645 (2009).","journal-title":"Cell Stem Cell"},{"key":"368_CR75","doi-asserted-by":"publisher","first-page":"10141","DOI":"10.1523\/JNEUROSCI.1054-16.2016","volume":"36","author":"C Lane-Donovan","year":"2016","unstructured":"Lane-Donovan, C. et al. Genetic restoration of plasma apoe improves cognition and partially restores synaptic defects in ApoE-deficient mice. J. Neurosci. 36, 10141\u201310150 (2016).","journal-title":"J. Neurosci."},{"key":"368_CR76","doi-asserted-by":"publisher","first-page":"e0229240","DOI":"10.1371\/journal.pone.0229240","volume":"15","author":"Y Tensaouti","year":"2020","unstructured":"Tensaouti, Y., Yu, T.-S. & Kernie, S. G. Apolipoprotein E regulates the maturation of injury-induced adult-born hippocampal neurons following traumatic brain injury. PLoS ONE 15, e0229240 (2020).","journal-title":"PLoS ONE"},{"key":"368_CR77","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1177\/0963689718808736","volume":"28","author":"C Yin","year":"2019","unstructured":"Yin, C., Guo, Z. D., He, Z. Z., Wang, Z. Y. & Sun, X. C. Apolipoprotein E affects in vitro axonal growth and regeneration via the MAPK signaling pathway. Cell Transplant. 28, 691\u2013703 (2019).","journal-title":"Cell Transplant."},{"key":"368_CR78","doi-asserted-by":"publisher","first-page":"851556","DOI":"10.3389\/fimmu.2022.851556","volume":"13","author":"AG Spiteri","year":"2022","unstructured":"Spiteri, A. G. et al. PLX5622 reduces disease severity in lethal cns infection by off-target inhibition of peripheral inflammatory monocyte production. Front. Immunol. 13, 851556 (2022).","journal-title":"Front. Immunol."},{"key":"368_CR79","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/gene.20183","volume":"44","author":"D Rempe","year":"2006","unstructured":"Rempe, D. et al. Synapsin I Cre transgene expression in male mice produces germline recombination in progeny. Genesis 44, 44\u201349 (2006).","journal-title":"Genesis"},{"key":"368_CR80","doi-asserted-by":"publisher","first-page":"D7","DOI":"10.1093\/nar\/gkv1290","volume":"44","author":"R Agarwala","year":"2016","unstructured":"Agarwala, R. et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 44, D7\u2013D19 (2016).","journal-title":"Nucleic Acids Res."},{"key":"368_CR81","doi-asserted-by":"publisher","first-page":"D884","DOI":"10.1093\/nar\/gkaa942","volume":"49","author":"KL Howe","year":"2021","unstructured":"Howe, K. L. et al. Ensembl 2021. Nucleic Acids Res. 49, D884\u2013D891 (2021).","journal-title":"Nucleic Acids Res."},{"key":"368_CR82","doi-asserted-by":"publisher","first-page":"D916","DOI":"10.1093\/nar\/gkaa1087","volume":"49","author":"A Frankish","year":"2021","unstructured":"Frankish, A. et al. GENCODE 2021. Nucleic Acids Res. 49, D916\u2013D923 (2021).","journal-title":"Nucleic Acids Res."},{"key":"368_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GXY Zheng","year":"2017","unstructured":"Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"368_CR84","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"368_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"368_CR86","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1093\/bioinformatics\/btaa1009","volume":"36","author":"C Ahlmann-Eltze","year":"2021","unstructured":"Ahlmann-Eltze, C. & Huber, W. glmGamPoi: fitting Gamma-Poisson generalized linear models on single cell count data. Bioinformatics 36, 5701\u20135702 (2021).","journal-title":"Bioinformatics"},{"key":"368_CR87","unstructured":"Blighe, K., Rana, S. & Lewis, M. EnhancedVolcano: publication-ready volcano plots with enhanced colouring and labeling. https:\/\/bioconductor.org\/packages\/devel\/bioc\/vignettes\/EnhancedVolcano\/inst\/doc\/EnhancedVolcano.html (2022)."},{"key":"368_CR88","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"368_CR89","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"368_CR90","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B Stat. Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B Stat. Methodol."},{"key":"368_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. M. & Walker, S. C. Fitting linear mixed-effects models using lme4. J. Stat. Soft. 67, 1\u201348 (2015).","journal-title":"J. Stat. Soft."}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-023-00368-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-023-00368-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-023-00368-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T14:17:27Z","timestamp":1728915447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-023-00368-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":91,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1038\/s43587-023-00368-3","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"23 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.H. is a co-founder and scientific advisory board member of E-Scape Bio and GABAeron. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}